| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody Magnitude Score: a new concept combining the extent and the strength of alloantibody
|
Ohto, Hitoshi
|
|
2001
|
25 |
3 |
p. 233-234
2 p.
|
artikel
|
| 2 |
Blood component safety
|
Seghatchian, Jerard
|
|
2001
|
25 |
3 |
p. 173-
1 p.
|
artikel
|
| 3 |
Continuous improvements in national leucodepletion outcome and potential cause of leucodepletion failure
|
Seghatchian, Jerard
|
|
2001
|
25 |
3 |
p. 221-224
4 p.
|
artikel
|
| 4 |
Current strategies for the provision of safer plasma and its derivatives: an update
|
Seghatchian, Jerard
|
|
2001
|
25 |
3 |
p. 185-187
3 p.
|
artikel
|
| 5 |
Current strategies on pathogen removal/inactivation: an overview
|
Allain, Jean-Pierre
|
|
2001
|
25 |
3 |
p. 195-197
3 p.
|
artikel
|
| 6 |
Enhanced arm cleansing, diversion of the first aliquot of donation, NAT and their impact on blood safety
|
Eglin, Roger
|
|
2001
|
25 |
3 |
p. 175-
1 p.
|
artikel
|
| 7 |
Frozen and washed red blood cells: new approaches and applications
|
Popovsky, Mark A
|
|
2001
|
25 |
3 |
p. 193-194
2 p.
|
artikel
|
| 8 |
Global views on leukodepletion, bacterial testing, viral removal/inactivation: Germany
|
Seitz, Rainer
|
|
2001
|
25 |
3 |
p. 203-204
2 p.
|
artikel
|
| 9 |
Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application
|
Corash, Laurence
|
|
2001
|
25 |
3 |
p. 179-181
3 p.
|
artikel
|
| 10 |
Leucodepletion, bacterial contamination and viral inactivation: a Portuguese blood centre experience
|
Vasconcelos, Eugenia
|
|
2001
|
25 |
3 |
p. 215-216
2 p.
|
artikel
|
| 11 |
Leucodepletion, bacterial testing and pathogen removal update and position for Scotland: April 2001
|
Prowse, C.V
|
|
2001
|
25 |
3 |
p. 217-218
2 p.
|
artikel
|
| 12 |
Leucodepletion (LD) trends and preferred approaches
|
Rowe, Graham
|
|
2001
|
25 |
3 |
p. 219-220
2 p.
|
artikel
|
| 13 |
Methylene blue and thionine in pathogen inactivation of plasma and platelet concentrates
|
Mohr, Harald
|
|
2001
|
25 |
3 |
p. 183-184
2 p.
|
artikel
|
| 14 |
[No title]
|
Rock, Gail
|
|
2001
|
25 |
3 |
p. 151-
1 p.
|
artikel
|
| 15 |
Optimal pool size and window period
|
Forčić, Dubravko
|
|
2001
|
25 |
3 |
p. 153-155
3 p.
|
artikel
|
| 16 |
Patent alerts for 25/1
|
|
|
2001
|
25 |
3 |
p. II-VIII
nvt p.
|
artikel
|
| 17 |
Pathogen inactivation of red cell concentrates using Inactine™ chemistry
|
Chapman, John
|
|
2001
|
25 |
3 |
p. 191-192
2 p.
|
artikel
|
| 18 |
Post-transfusion alloimmunization to granulocytes and platelets in Japanese patients as determined by the MPHA method
|
Zhang, Xiaoling
|
|
2001
|
25 |
3 |
p. 163-172
10 p.
|
artikel
|
| 19 |
Prioritizing the options for enhancing blood component safety
|
Barbara, John
|
|
2001
|
25 |
3 |
p. 225-
1 p.
|
artikel
|
| 20 |
Strategies for improving the safety of blood collection and transfusion: the Genoa experience
|
Valbonesi, M
|
|
2001
|
25 |
3 |
p. 207-208
2 p.
|
artikel
|
| 21 |
The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components
|
Krailadsiri, Pranee
|
|
2001
|
25 |
3 |
p. 177-178
2 p.
|
artikel
|
| 22 |
The quality of methylene blue treated FFP and cryo
|
Seghatchian, Jerard
|
|
2001
|
25 |
3 |
p. 227-231
5 p.
|
artikel
|
| 23 |
Transfusion medicine in Norway 2001. Time for change
|
Flesland, O
|
|
2001
|
25 |
3 |
p. 211-214
4 p.
|
artikel
|
| 24 |
Troponin I concentrations of shed blood might influence monitoring of myocardial injury after coronary operations
|
Asghar Peivandi, Ali
|
|
2001
|
25 |
3 |
p. 157-162
6 p.
|
artikel
|
| 25 |
Universal leukoreduction in Iceland
|
Gudmundsson, Sveinn
|
|
2001
|
25 |
3 |
p. 205-206
2 p.
|
artikel
|
| 26 |
Universal leukoreduction in the Netherlands
|
Pietersz, Ruby N.I
|
|
2001
|
25 |
3 |
p. 209-210
2 p.
|
artikel
|
| 27 |
Upcoming events
|
|
|
2001
|
25 |
3 |
p. IX-X
nvt p.
|
artikel
|
| 28 |
Up-date on blood component safety: current position of the national blood service in England
|
Nicholson, G
|
|
2001
|
25 |
3 |
p. 199-200
2 p.
|
artikel
|
| 29 |
Use of riboflavin for photoinactivation of pathogens in blood components
|
Schuyler, Robert
|
|
2001
|
25 |
3 |
p. 189-190
2 p.
|
artikel
|
| 30 |
Where are we in France?
|
Chabanel, Anne
|
|
2001
|
25 |
3 |
p. 201-202
2 p.
|
artikel
|
Tijdschrift beschrijving